These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6872549)

  • 41. Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin.
    Qi R; Ozaki Y; Satoh K; Kurota K; Asazuma N; Yatomi Y; Kume S
    Thromb Res; 1996 Jan; 81(1):43-54. PubMed ID: 8747519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
    Grobecker H; Gessler I; Delius W; Dominiak P; Kees F
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus.
    Pietraszek MH; Takada Y; Taminato A; Yoshimi T; Watanabe I; Takada A
    Thromb Res; 1993 Apr; 70(2):131-8. PubMed ID: 8322284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin-induced platelet aggregation in whole blood and the effects of ketanserin and mepyramine.
    Bevan J; Heptinstall S
    Thromb Res; 1985 Apr; 38(2):189-94. PubMed ID: 3159127
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
    Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
    Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of 5-hydroxytryptamine in the feline response to intravenous infusion of live E. coli.
    Arvidsson S; Falk A; Haglind E; Haglund U
    Br J Pharmacol; 1983 Jul; 79(3):711-8. PubMed ID: 6360276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
    Lichtenthal PR; Wade LD; Rossi EC
    Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antithrombotic activity of SR 46349, a novel, potent and selective 5-HT2 receptor antagonist.
    Herbert JM; Bernat A; Barthelemy G; Dol F; Rinaldi M
    Thromb Haemost; 1993 Mar; 69(3):262-7. PubMed ID: 8470049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin and the blood vessel wall.
    Van Nueten JM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S49-51. PubMed ID: 2412058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307.
    Verdouw PD; Jennewein HM; Heiligers J; Duncker DJ; Saxena PR
    Eur J Pharmacol; 1984 Jul; 102(3-4):499-509. PubMed ID: 6548449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ketanserin on pulmonary hemodynamics, lung mechanics, and gas exchange in endotoxemic pigs.
    Olson NC; Grizzle MK; Anderson DL
    Am J Vet Res; 1986 Oct; 47(10):2193-6. PubMed ID: 3777645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of platelet-derived contractile agents on human digital arteries.
    Moulds RF; Iwanov V; Medcalf RL
    Clin Sci (Lond); 1984 Apr; 66(4):443-51. PubMed ID: 6697664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
    Pawlak D; Pawlak K; Chabielska E; Małyszko J; Takada A; Myśliwiec M; Buczko W
    Thromb Res; 1998 Jun; 90(6):259-70. PubMed ID: 9700856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of serotonin and its antagonist ketanserin on pial vessels.
    Auer LM; Leber K; Sayama I
    J Cereb Blood Flow Metab; 1985 Dec; 5(4):517-22. PubMed ID: 2932453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of 5-hydroxytryptamine in endotoxin-induced respiratory failure of pigs.
    Olson NC
    Am Rev Respir Dis; 1987 Jan; 135(1):93-9. PubMed ID: 3541719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
    Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
    Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.